Hydrogels for combination delivery of antineoplastic agents

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Oncology

Background:

• Systemic delivery of anticancer agents presents challenges in efficacy and safety.
• Localized drug delivery offers a promising alternative for enhanced therapeutic outcomes.
• Novel hydrogel systems are needed for controlled release of antineoplastic agents.

Purpose of the Study:

• To design and synthesize a novel biodegradable hydrogel for localized delivery of antineoplastic agents.
• To demonstrate tunable drug release mechanisms from the hydrogel using model drugs.
• To evaluate the potential of this hydrogel system for localized cancer treatment.

Main Methods:

• Alginate was chemically modified and cross-linked with adipic dihydrazide to create biodegradable hydrogels.
• Three model antineoplastic agents (methotrexate, doxorubicin, mitoxantrone) were loaded into the hydrogel.
• Drug release was achieved through diffusion, hydrolytic cleavage of a labile linker, and ionic complex dissociation.

Main Results:

• The hydrogel system successfully encapsulated and released three model antineoplastic agents.
• Methotrexate was released via diffusion from the hydrogel matrix.
• Doxorubicin release was controlled by hydrolytic degradation of a linker, while mitoxantrone release occurred via ionic complex dissociation.
• The study demonstrated three distinct drug release mechanisms from the novel hydrogel.

Conclusions:

• A novel biodegradable hydrogel system capable of localized antineoplastic agent delivery was successfully developed.
• The hydrogel enables tunable drug release profiles based on the drug's chemical properties and loading mechanism.
• This versatile drug delivery platform holds significant potential for localized cancer therapy, accommodating single or combination drug delivery.